KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Shares Repurchased (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Shares Repurchased for 17 consecutive years, with $300.0 million as the latest value for Q4 2025.

  • Quarterly Shares Repurchased rose 98.68% to $300.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $726.0 million through Dec 2025, up 70.42% year-over-year, with the annual reading at $450.0 million for FY2025, 198.01% up from the prior year.
  • Shares Repurchased hit $300.0 million in Q4 2025 for Quest Diagnostics, up from $151.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $1.5 billion in Q2 2021 to a low of $151.0 million in Q4 2024.
  • Historically, Shares Repurchased has averaged $433.3 million across 5 years, with a median of $336.5 million in 2022.
  • Biggest five-year swings in Shares Repurchased: surged 446.67% in 2021 and later tumbled 86.67% in 2022.
  • Year by year, Shares Repurchased stood at $289.0 million in 2021, then surged by 59.52% to $461.0 million in 2022, then plummeted by 40.35% to $275.0 million in 2023, then crashed by 45.09% to $151.0 million in 2024, then soared by 98.68% to $300.0 million in 2025.
  • Business Quant data shows Shares Repurchased for DGX at $300.0 million in Q4 2025, $151.0 million in Q4 2024, and $275.0 million in Q4 2023.